Thus, we further investigated the outcomes of a triple combination of SUP3, Flt3L and PD-L1 blockade (Supplementary Fig S7A), and observed that this triple treatment exhibited the strongest suppression of B16F10 tumor growth (Fig. 7G). The gene discussed is FLT3LG; the disease is neoplasm.